AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 29.68
arrow_downward
-0.70%(-0.21) Siku 1
US$ 29.68
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 18 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.57
Juu
US$ 30.48
Chini
US$ 29.22
Mtaji wa soko
1.78B
Wastani wa kiasi cha mauzo
1.21M
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 22.24
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.57
Juu
US$ 30.48
Chini
US$ 29.22
Mtaji wa soko
1.78B
Wastani wa kiasi cha mauzo
1.21M
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 22.24
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Business Insider
·
saa 1 iliyopita
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
The Motley Fool
·
saa 1 iliyopita
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Barron's
·
saa 11 zilizopita
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Yahoo Finance
·
saa 5 zilizopita
Stock Market: Will S&P 500 Open Up or Down Today?
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com